# Naproxen Sodium PM

NDC: 70677-0064
Generic name: Naproxen Sodium
Labeler / Manufacturer: Strategic Sourcing Services LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20181231
Marketing ended: 20261231
FDA application: ANDA209726

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70677-0064"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70677-0064
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03a331d8-c957-4949-894f-51d9bd15e0d0